494 related articles for article (PubMed ID: 8551486)
1. White coat effect in treated hypertensive patients: sex differences.
Myers MG; Reeves RA
J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
[TBL] [Abstract][Full Text] [Related]
2. Determinants of the white-coat effect in hypertensive subjects.
Mansoor GA; McCabe EJ; White WB
J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
[TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
4. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
5. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
[TBL] [Abstract][Full Text] [Related]
6. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in office and ambulatory control of hypertension.
Banegas JR; Segura J; de la Sierra A; Gorostidi M; Rodríguez-Artalejo F; Sobrino J; de la Cruz JJ; Vinyoles E; del Rey RH; Graciani A; Ruilope LM;
Am J Med; 2008 Dec; 121(12):1078-84. PubMed ID: 19028204
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of white-coat response in patients with treated hypertension.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
10. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
[TBL] [Abstract][Full Text] [Related]
11. Self-measured home blood pressure in predicting ambulatory hypertension.
Mansoor GA; White WB
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1017-22. PubMed ID: 15533727
[TBL] [Abstract][Full Text] [Related]
12. White coat effect and white coat hypertension in pediatric patients.
Matsuoka S; Kawamura K; Honda M; Awazu M
Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
[TBL] [Abstract][Full Text] [Related]
13. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].
Villeneuve F; Rosenbaum D; Gury C; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between body-mass index and white-coat hypertension among referred patients.
Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
16. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
[TBL] [Abstract][Full Text] [Related]
17. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
[TBL] [Abstract][Full Text] [Related]
18. True resistant hypertension: is it possible to be recognized in the office?
Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
[TBL] [Abstract][Full Text] [Related]
19. White-coat hypertension and cardiac organ damage in elderly subjects.
Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V
J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402
[TBL] [Abstract][Full Text] [Related]
20. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
